Searchable abstracts of presentations at key conferences in endocrinology

ea0081p723 | Thyroid | ECE2022

Metastatic papillary thyroid carcinoma without identifiable primary tumor in a patient with IgG4-related thyroiditis: challenging diagnosis and management of a rare case

Papadimitriou Kasiani , Moustaki Melpomeni′ , Tsitsimpis Anastasios , Papanikola Nektaria , Dermentzoglou Alexandros , Spanou Loukia , Vryonidou Andromahi

Introduction: IgG4-related thyroiditis (IgG4-RTD) is a rare fibroinflammatory disorder. It is characterized by dense lymphocyte infiltration (mainly IgG4+ plasma cells), enlargement and dysfunction of the thyroid gland. IgG4-RTD includes mostly cases of Hashimoto’s (HT) but also of Riedel’s and Graves’ thyroiditis. Diagnosis is set according to imaging and histopathological criteria. Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer (~9...

ea0090p373 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Glycemic control in Type 1 Diabetes patients using multiple daily insulin injections (MDII) vs continuous subcutaneous insulin infusion (CSII)

Tsitsimpis Anastasios , Cherolidi Helen , Kalogeris Nikolaos , Spanou Loukia , Mouslech Tzant , Somali Maria , Georgiopoulos Georgios , Vryonidou Andromachi

Objective: Glycemic control of patients with type 1 diabetes is mainly based on insulin administration. The ongoing technological developments in continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) provide new treatment strategies, with better glycemic control. This study assessed the clinical impact of two treatment strategies in adults with type 1 diabetes (T1D): multiple daily insulin injections (MDII) vs continuous subcutaneous insulin i...

ea0099ep1290 | Late Breaking | ECE2024

Diagnosis of MEN-1 syndrome with multiple tumor locations and a rare genetic mutation

Tsitsimpis Anastasios , Papadimitriou Kasiani , Papanikolaou Vasiliki , Rigana Maria , Barkas Konstantinos , Nastos Konstantinos , Vryonidou Andromahi

Introduction: Most of pituitary adenomas are sporadic, with only 5% of them attributed to genetic mutations and syndromes such as Multiple Endocrine Neoplasia type 1 (MEN-1). However, how easy is it for a doctor to suspect it when there is no known family history?Case Presentation: A 36-year-old patient with no personal or family history presented to our Endocrine Department reporting intermittent episodes of unconsciousness during the last 48 hours. The...

ea0099p193 | Late-Breaking | ECE2024

A patient with an adrenal adenoma and pituitary and intracranial meningiomas due to an ARMC5 mutation

Papadimitriou Kasiani , Tsitsimpis Anastasios , Moustaki Melpomeni , Rigana Maria , Kalogeris Nikolaos , Barkas Konstantinos , Nastos Konstantinos , Stratakis Constantine , Vryonidou Andromahi

Introduction: Armadillo-containing repeat protein 5 gene (ARMC5) is a tumor suppressor gene expressed in different human tissues. Inactivating germline and somatic mutations of the gene are involved in the pathogenesis of primary bilateral macronodular adrenocortical hyperplasia (PBMAH). These mutations are mainly met in the familial form of PBMAH and are associated with a more severe Cushing Syndrome, meningiomas and T-cell immune response defects. However, the role of ARMC5 ...